TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
202 hedge funds and large institutions have $4.21B invested in Turning Point Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 70 increasing their positions, 80 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
13% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 80
20% less capital invested
Capital invested by funds: $5.28B → $4.21B (-$1.07B)
Holders
202
Holding in Top 10
4
Calls
$7.61M
Puts
$3.16M
Top Buyers
| 1 | +$47.3M | |
| 2 | +$42.6M | |
| 3 | +$37.4M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$33.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.8M |
Top Sellers
| 1 | -$36.3M | |
| 2 | -$20.3M | |
| 3 | -$16.7M | |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$14.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.5M |